Organon CEO Resignation and Interim Appointment Following Audit Investigation

Organon & Co. announced the resignation of CEO Kevin Ali on October 26, 2025, following an investigation into the company's wholesaler sales practices. Joseph Morrissey, the current Executive Vice President and Head of Manufacturing & Supply, was appointed as Interim CEO. The investigation, led by the Audit Committee, found improper sales practices related to the Nexplanon product, which enabled the company to meet revenue expectations. Although no financial restatements are required, the company is addressing material weaknesses in internal controls. The Board has initiated a search for a permanent CEO and appointed Carrie S. Cox as Executive Chair to support Morrissey during the transition.